HR Execs on the Move

Leeds Equity Partners

www.leedsequity.com

 
Leeds Equity Partners is a New York, NY-based company in the Financial Services sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Gordian Group

Gordian Group is a New York, NY-based company in the Financial Services sector.

ClariFI

ClariFI is one of the leading companies in the Financial Services sector.

Morrison and Associates

Morrison & Associates is a Tempe, AZ-based company in the Financial Services sector.

BDA Partners

BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 20 years` experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Tokyo, Seoul, Shanghai, Hong Kong, Ho Chi Minh City, Singapore and Mumbai. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn our clients` trust by delivering insightful advice and outstanding outcomes. BDA carries out its US securities business through BDA Advisors Inc, a broker-dealer registered with the US Securities and Exchange Commission (SEC) and a member of FINRA and SIPC. BDA`s UK subsidiary is authorised and regulated by the Financial Conduct Authority. In Hong Kong, Business Development Asia Ltd. is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.

Patient Square Capital

Patient Square Capital is a dedicated health care investment firm that will make outstanding investments by partnering with best-in-class management teams whose products, services and technologies improve health. Patient Square leverages its deep and established network to seek opportunities to deploy capital in companies across the broad health care industry with targets including biopharmaceuticals, pharmaceutical value chain, medical devices, diagnostics, providers, technology-enabled services, digital and consumer health sectors.